Vanguard Personalized Indexing Management, LLC Avidity Biosciences, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 9,159 shares of RNA stock, worth $332,196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,159
Previous 7,373
24.22%
Holding current value
$332,196
Previous $217,000
19.82%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RNA
# of Institutions
243Shares Held
116MCall Options Held
289KPut Options Held
998K-
Janus Henderson Group PLC London, X011.4MShares$414 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$411 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$351 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$335 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$317 Million4.23% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.89B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...